SNGLR Capital AG

Zug, Switzerland
Venture Capital
Active
Total investments

1

Portfolio companies

1

Rounds per year

1.00

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareTherapeuticsBiopharma

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistHealthcareMobilityAI/Big DataBlockchain/Crypto/Web3 Show 4 more
Stage focus
Series BSeedSeries A
Geo focus
AlbaniaAndorraAustriaBelgiumBosnia and Herzegovina Show 39 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
1
Lead investments
0
Rounds per year
1.00
Investments by industry
  • Health Care (1)
  • Therapeutics (1)
  • Biopharma (1)
  • Biotechnology (1)
Investments by region
  • Switzerland (1)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Lindus HealthAug 16, 2023Clinical Trials, Technology PlatformEarly stage18000000 USD London, England
BillionToOneDec 19, 2022Liquid Biopsy, Molecular Counting Technology, Molecular Diagnostics, Non-Invasive Prenatal Testing, Non-Invasive Prenatal Test (NIPT), Oncology, Precision Diagnostics, QCT Molecular Counter Platform-48500000 USD Menlo Park, California
NeomoonJun 30, 2022Digital Bank, Financial Solutions, StablecoinEarly stage850000 USD Miami, Florida
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.